Global siRNA Drug Competitive Landscape Professional Research Report 2025
Description
Global siRNA Drug Competitive Landscape Professional Research Report 2025
Research Summary
An siRNA drug, short for small interfering RNA drug, is a type of therapeutic agent that utilizes synthetic RNA molecules to selectively silence the expression of specific disease-causing genes. These drugs are designed to target and inhibit the production of messenger RNA (mRNA) molecules that encode proteins involved in various diseases, ranging from viral infections to genetic disorders and cancer. By harnessing the natural mechanism of RNA interference, siRNA drugs offer a potent and highly specific approach to gene regulation, with the potential to treat a wide range of medical conditions. They are typically administered via various delivery methods, including nanoparticles, to ensure efficient uptake by target cells and achieve therapeutic effects. Ongoing research aims to optimize the design and delivery of siRNA drugs, addressing challenges such as off-target effects and immune response, to enhance their safety and efficacy in clinical applications.
According to DIResearch's in-depth investigation and research, the global siRNA Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of siRNA Drug include Genzyme, Alnylam, Dicerna, Quark Pharmaceuticals, Arrowhead, Exicure, Miragen Therapeutics, Silence, Sylentis, Avidity Biosciences, Dicerna, BioNTech, Moderna Therapeutics, The WhiteOak Group, Inc. etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of siRNA Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global siRNA Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the siRNA Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of siRNA Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of siRNA Drug Include:
Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
siRNA Drug Product Segment Include:
Givlaari
Patisiran
Givosiran
siRNA Drug Product Application Include:
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global siRNA Drug Industry PESTEL Analysis
Chapter 3: Global siRNA Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global siRNA Drug Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global siRNA Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global siRNA Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 siRNA Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 siRNA Drug Product by Type
- 1.2.1 Givlaari
- 1.2.2 Patisiran
- 1.2.3 Givosiran
- 1.3 siRNA Drug Product by Application
- 1.3.1 Single Gene Rare Disease
- 1.3.2 Protein Deposition Disease
- 1.3.3 Chronic Liver Disease
- 1.3.4 Others
- 1.4 Global siRNA Drug Market Revenue and Sales Analysis
- 1.4.1 Global siRNA Drug Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global siRNA Drug Sales Market Size Analysis (2020-2032)
- 1.4.3 Global siRNA Drug Market Sales Price Trend Analysis (2020-2032)
- 1.5 siRNA Drug Industry Trends and Innovation
- 1.5.1 siRNA Drug Industry Trends and Innovation
- 1.5.2 siRNA Drug Market Drivers and Challenges
- 2 siRNA Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 siRNA Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global siRNA Drug Market Analysis by Regions
- 4.1 siRNA Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global siRNA Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global siRNA Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global siRNA Drug Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global siRNA Drug Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global siRNA Drug Sales and Market Share by Region (2020-2025)
- 4.3.2 Global siRNA Drug Sales Forecast by Region (2026-2032)
- 4.4 Global siRNA Drug Sales Price Trend Analysis (2020-2032)
- 5 Global siRNA Drug Market Size by Type and Application
- 5.1 Global siRNA Drug Market Size by Type
- 5.1.1 Global siRNA Drug Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global siRNA Drug Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global siRNA Drug Market Size by Application
- 5.2.1 Global siRNA Drug Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global siRNA Drug Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America siRNA Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America siRNA Drug Market Size by Type
- 6.3.1 North America siRNA Drug Sales by Type (2020-2032)
- 6.3.2 North America siRNA Drug Revenue by Type (2020-2032)
- 6.4 North America siRNA Drug Market Size by Application
- 6.4.1 North America siRNA Drug Sales by Application (2020-2032)
- 6.4.2 North America siRNA Drug Revenue by Application (2020-2032)
- 6.5 North America siRNA Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe siRNA Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe siRNA Drug Market Size by Type
- 7.3.1 Europe siRNA Drug Sales by Type (2020-2032)
- 7.3.2 Europe siRNA Drug Revenue by Type (2020-2032)
- 7.4 Europe siRNA Drug Market Size by Application
- 7.4.1 Europe siRNA Drug Sales by Application (2020-2032)
- 7.4.2 Europe siRNA Drug Revenue by Application (2020-2032)
- 7.5 Europe siRNA Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China siRNA Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China siRNA Drug Market Size by Type
- 8.3.1 China siRNA Drug Sales by Type (2020-2032)
- 8.3.2 China siRNA Drug Revenue by Type (2020-2032)
- 8.4 China siRNA Drug Market Size by Application
- 8.4.1 China siRNA Drug Sales by Application (2020-2032)
- 8.4.2 China siRNA Drug Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) siRNA Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) siRNA Drug Market Size by Type
- 9.3.1 APAC (excl. China) siRNA Drug Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) siRNA Drug Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) siRNA Drug Market Size by Application
- 9.4.1 APAC (excl. China) siRNA Drug Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) siRNA Drug Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) siRNA Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America siRNA Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America siRNA Drug Market Size by Type
- 10.3.1 Latin America siRNA Drug Sales by Type (2020-2032)
- 10.3.2 Latin America siRNA Drug Revenue by Type (2020-2032)
- 10.4 Latin America siRNA Drug Market Size by Application
- 10.4.1 Latin America siRNA Drug Sales by Application (2020-2032)
- 10.4.2 Latin America siRNA Drug Revenue by Application (2020-2032)
- 10.5 Latin America siRNA Drug Market Size by Country
- 10.6 Latin America siRNA Drug Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa siRNA Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa siRNA Drug Market Size by Type
- 11.3.1 Middle East & Africa siRNA Drug Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa siRNA Drug Revenue by Type (2020-2032)
- 11.4 Middle East & Africa siRNA Drug Market Size by Application
- 11.4.1 Middle East & Africa siRNA Drug Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa siRNA Drug Revenue by Application (2020-2032)
- 11.5 Middle East siRNA Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global siRNA Drug Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global siRNA Drug Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global siRNA Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global siRNA Drug Average Sales Price by Manufacturers (2021-2025)
- 12.2 siRNA Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 siRNA Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Genzyme
- 13.1.1 Genzyme Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Genzyme siRNA Drug Product Portfolio
- 13.1.3 Genzyme siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Alnylam
- 13.2.1 Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Alnylam siRNA Drug Product Portfolio
- 13.2.3 Alnylam siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Dicerna
- 13.3.1 Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Dicerna siRNA Drug Product Portfolio
- 13.3.3 Dicerna siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Quark Pharmaceuticals
- 13.4.1 Quark Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Quark Pharmaceuticals siRNA Drug Product Portfolio
- 13.4.3 Quark Pharmaceuticals siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Arrowhead
- 13.5.1 Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Arrowhead siRNA Drug Product Portfolio
- 13.5.3 Arrowhead siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Exicure
- 13.6.1 Exicure Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Exicure siRNA Drug Product Portfolio
- 13.6.3 Exicure siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Miragen Therapeutics
- 13.7.1 Miragen Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Miragen Therapeutics siRNA Drug Product Portfolio
- 13.7.3 Miragen Therapeutics siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Silence
- 13.8.1 Silence Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Silence siRNA Drug Product Portfolio
- 13.8.3 Silence siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Sylentis
- 13.9.1 Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Sylentis siRNA Drug Product Portfolio
- 13.9.3 Sylentis siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Avidity Biosciences
- 13.10.1 Avidity Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Avidity Biosciences siRNA Drug Product Portfolio
- 13.10.3 Avidity Biosciences siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Dicerna
- 13.11.1 Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Dicerna siRNA Drug Product Portfolio
- 13.11.3 Dicerna siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 BioNTech
- 13.12.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 BioNTech siRNA Drug Product Portfolio
- 13.12.3 BioNTech siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 Moderna Therapeutics
- 13.13.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Moderna Therapeutics siRNA Drug Product Portfolio
- 13.13.3 Moderna Therapeutics siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 The WhiteOak Group, Inc.
- 13.14.1 The WhiteOak Group, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 The WhiteOak Group, Inc. siRNA Drug Product Portfolio
- 13.14.3 The WhiteOak Group, Inc. siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 siRNA Drug Industry Chain Analysis
- 14.2 siRNA Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 siRNA Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 siRNA Drug Typical Downstream Customers
- 14.4 siRNA Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
